| Katie Yadusky, LCSWA | |
|
505 Reedy Creek Rd, Cary, NC 27513-4117 | |
| (919) 446-4933 | |
| Not Available |
| Full Name | Katie Yadusky |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 505 Reedy Creek Rd, Cary, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043837602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | P010737 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katie Yadusky, LCSWA 4108 Wingate Dr, Raleigh, NC 27609-6053 Ph: () - | Katie Yadusky, LCSWA 505 Reedy Creek Rd, Cary, NC 27513-4117 Ph: (919) 446-4933 |
News Archive
The UK government is trying its best to rescue Britons from Wuhan City in Hubei Province, ground zero for the emergence of the deadly virus, 2019-NCov or the Wuhan coronavirus. Just like other residents trapped in the city, the Britons clamor to escape this unfortunate situation, as the virus continues to spread, taking more than 170 lives, and infecting more than 7,000 people.
Today marks the 20th anniversary of the international Convention on the Rights of the Child, adopted by the United Nations on November 20, 1989. The CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are joining forces to highlight the importance of this day, a reminder of the many injustices committed against children around the world.
Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has entered into an agreement to acquire a minority ownership in Westborough, MA, based Aciex Therapeutics Inc., an ophthalmic drug development company with a focus on developing novel therapeutics to treat ocular diseases.
Recent research from the laboratory of Michael Karin, PhD, at the University of California, San Diego School of Medicine - the first researcher to demonstrate a molecular link between inflammation and cancer - has identified two potential targets for the prevention and treatment of colitis-associated cancer (CAC), the most serious complication of inflammatory bowel disease.
Pacira Pharmaceuticals, Inc., announced today that its second Phase III placebo controlled study of EXPAREL(TM) (DepoBupivacaine) met its primary endpoint.
› Verified 1 days ago
Ms. Karae Nakemia Mcghee King Powers Carey, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1330 Se Maynard Rd, Suite 102, Cary, NC 27511 Phone: 919-454-7857 | |
Jonnie Seay Lane, LCAS, LPC, CCS Counselor Medicare: Not Enrolled in Medicare Practice Location: 106 Ridge View Dr Ste C, Cary, NC 27511 Phone: 252-327-3791 | |
Mr. Orlando Santos Jesalva Jr., M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 310 Powers Ferry Rd, Cary, NC 27519 Phone: 919-342-5512 | |
Mckeen Akwaja, Counselor Medicare: Not Enrolled in Medicare Practice Location: 111 Mackenan Dr, Cary, NC 27511 Phone: 980-819-0010 | |
Jana Bester Richardson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 111 Mackenan Dr, Cary, NC 27511 Phone: 919-371-2848 | |
Achaia Dent, LCMHCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 1240 Se Maynard Rd Ste 104, Cary, NC 27511 Phone: 919-709-7307 | |
Van T. Langeland, M.S. Counselor Medicare: Not Enrolled in Medicare Practice Location: 106-d Ridgeview Dr, Cary, NC 27511 Phone: 919-476-9995 |